Craig Foster, Ondo InsurTech, discusses the expanded partnership with Nationwide in the US. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.50
Bid: 1.40
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.20 (14.286%)
Open: 1.50
High: 1.50
Low: 1.45
Prev. Close: 1.50

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Leap Gaming Update – Offer Declared Unconditional

11 Apr 2023 07:00

RNS Number : 6790V
Seed Innovations Limited
11 April 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR').

 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

11 April 2023

SEED Innovations Ltd ("SEED" or, the "Company")

 

 Leap Gaming Update - Offer Declared Unconditional

Divestment will secure approximately €5.8m Cash to the Company over 2 year period

 

SEED Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, is pleased to announce that, further to the announcement of 7 December 2022, the sale of portfolio company Fralis LLC (trading as Leap Gaming, 'Leap'), is now unconditional and completion has occurred ('Completion').

 

As previously announced, Leap entered into a conditional Sale & Purchase Agreement ('SPA') for the sale of the remainder of Leap to existing unitholder IMG Arena US, LLC ('IMG') based upon an enterprise value of €14 million (the 'Leap Transaction'). IMG is an existing investor in, and was the second largest owner of, Leap. Following the transaction, Leap will be wholly owned by IMG.

 

Sale proceeds due to SEED will be received by the Company in the coming days as follows:

 

· €2.8 million being 50% of the sale proceeds due to SEED under the agreement (and after adjustment for working capital and repayment of debt); and

 

· €268,000 being repayment of the Company's €250,000 term loan (as announced on 8 June 2022), together with accrued interest.

 

The second tranche of sale proceeds, being €2.8 million (calculated as the remaining 50% of the sale proceeds and subject only to any claims under customary warranties & indemnities,), is expected to be received in April 2024, being the 12-month anniversary of Completion, as per the terms of the SPA.

 

The Company intends to use the proceeds received for making further investments in accordance with its investing policy.

 

Ed McDermott, CEO, commented: "I am pleased to be able to confirm to shareholders that the sale of Leap to IMG Arena has been declared unconditional and has concluded in line with the anticipated timelines. The initial cash proceeds, and the balance paid on the 12-month anniversary of Completion, provides us with liquidity at a time where we are seeing some very promising investment opportunities. We strongly believe that our portfolio has the potential to create short, medium- and long-term value creation. 

 

"We wish Leap and IMG well in the future."

 

 

ENDS

 

For further information on the Company please visit www.seedinnovations.co or contact:

 

Ed McDermott /

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co

 

James Biddle /

Roland Cornish

Beaumont Cornish Limited,

Nomad

 

T: +44 (0) 207 628 3396

Isabella Pierre /

Damon Heath

Shard Capital Partners LLP

 

T: +44 (0)20 7186 9927

Catherine Leftley /Isabelle Morris/

Max Bennett

St Brides Partners Ltd,

Financial PR

 

E: info@stbridespartners.co.uk

 

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

Leap is a developer of high-end virtual-sports, slots, and casino applications serving hundreds of gaming brands and generating tens of thousands of engagement points with end-users. Leap's attention to detail in its solutions and services is manifested in the modular engagement terms it offers to its operating partners and its ability to provide seamless experiences across mobile, desktop and retail environments. Leap is licensed by the MGA and certified for other jurisdictions worldwide, including the United Kingdom, Sweden, the Netherlands, Romania, South Africa and Greece.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEADLKESLDEFA
Date   Source Headline
11th Nov 202412:43 pmRNSPortfolio Update
17th Oct 202412:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
8th Oct 20247:24 amRNSPortfolio Update
24th Sep 20247:00 amRNSAGM Statement
2nd Sep 202412:35 pmRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSNotice of AGM
29th Aug 20247:00 amRNSDirector Share Purchase
16th Aug 20242:55 pmRNSChange of Registered Address
7th Aug 202411:40 amRNSNew Investment: Pantheon Resources plc
30th Jul 20242:39 pmRNSHolding(s) in Company
23rd Jul 20247:00 amRNSInvestee Company Update: Little Green Pharma Ltd
19th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSCompletion of share buy-back programme
31st May 20245:29 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th May 20244:34 pmRNSTransaction in Own Shares & TVR
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSTransaction in Own Shares & TVR
22nd May 202411:51 amRNSTransaction in Own Shares & TVR
21st May 20247:00 amRNSTransaction in Own Shares & TVR
20th May 20247:00 amRNSTransaction in Own Shares & TVR
17th May 20247:00 amRNSTransaction in Own Shares
16th May 20247:00 amRNSTransaction in Own Shares & TVR
14th May 202412:52 pmRNSTransaction in Own Shares
13th May 20241:51 pmRNSTransaction in Own Shares
13th May 20247:00 amRNSTransaction in Own Shares
10th May 20247:00 amRNSTransaction in Own Shares & TVR
3rd May 20244:06 pmRNSTransaction in Own Shares & TVR
3rd May 20247:00 amRNSTransaction in Own Shares & TVR
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares & TVR
26th Apr 20244:46 pmRNSTransaction in Own Shares
25th Apr 202411:03 amRNSTransaction in Own Shares
24th Apr 20243:14 pmRNSTransaction in Own Shares & TVR
23rd Apr 202411:11 amRNSTransaction in Own Shares
22nd Apr 202411:33 amRNSTransaction in Own Shares
19th Apr 202410:55 amRNSTransaction in Own Shares & TVR
18th Apr 20241:20 pmRNSTransaction in Own Shares
17th Apr 20242:57 pmRNSInvestee Company Update: Little Green Pharma Ltd
17th Apr 202411:55 amRNSTransaction in Own Shares & TVR
16th Apr 20247:00 amRNSSpecial Dividend Declaration
15th Apr 20243:20 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSReceipt of remaining £2.4m from sale of Leap
12th Apr 20247:00 amRNSTransaction in Own Shares & TVR
9th Apr 20241:00 pmRNSInvestee Company Update: Northern Leaf plc
8th Apr 202412:20 pmRNSTransaction in Own Shares & TVR
5th Apr 20248:25 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20243:34 pmRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Track Your Investments

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.